NSG 124, Pharmacology, Nursing Exam 1:
(Latest 2026/2027 Update) 100% Verified
Actual Questions & Answers | Grade A -
Herzing University
This NSG 124 Exam 1 practice resource is a comprehensive study guide designed to help
nursing students ace their foundational pharmacology exams. Featuring 100 carefully curated,
multiple-choice questions, it thoroughly breaks down essential drug classifications, therapeutic
effects, adverse reactions, and core nursing considerations.
Why This Practice Exam Sells
This resource is highly sought after by students because it focuses exactly on the most tested
concepts in first-year nursing pharmacology. Highlighting it with the following points will help
you attract buyers:
• Comprehensive ADME Coverage: Questions specifically test the core
pharmacokinetics principles: Absorption, Distribution, Metabolism, and Excretion.
• Detailed, Verified Answers: Every question includes a clear, evidence-based Answer
• Drug Classification Mastery: Helps students easily differentiate between chemical,
generic, and trade (brand) drug names, and understand concepts like the therapeutic
index and half-life.
• Real Nursing Scenarios: Features application-based questions that prepare students
for the critical thinking required in actual nursing school exams and clinical settings.
• Format: Delivered as a clear, instantly downloadable PDF that can be studied
anywhere, anytime.
Listing & Tags
• Title: NSG 124 Exam 1: 100 Practice Questions & Verified Answers
• Tags: NSG 124, Pharmacology, Nursing Exam 1, Herzing University, Practice
Questions, Test Bank, Study Guide
Q1. Explain what it means for a drug to be teratogenic and what outcomes it can
cause for a fetus. [Short Answer]
1
, Answer: A teratogenic drug can interfere with fetal development, resulting in congenital
malformations (birth defects) or causing fetal death. It implies the drug poses risks to the
developing embryo or fetus if exposure occurs during pregnancy.
Explanation: Teratogenicity refers to a drug's capacity to harm a developing fetus. A complete
answer notes that teratogens can produce structural defects (birth defects) or lead to loss of the
fetus (fetal death), and links this to the drug acting during developmental stages when the
embryo or fetus is vulnerable.
Q2. Which is preferable regarding a drug's therapeutic range? [Multiple Choice]
A) A low therapeutic index
B) No difference between narrow and wide
C) Narrow therapeutic range
D) Wide therapeutic range
Answer: Wide therapeutic range
Explanation: A wide therapeutic range is preferable because it provides a larger margin between
effective and toxic concentrations, making dosing safer and less likely to cause toxicity. A narrow
therapeutic range means there is a small margin for error and higher risk of toxicity. 'A low
therapeutic index' signals increased risk (the opposite of a wide safe margin). Saying 'no
difference' is incorrect because the width of the therapeutic range affects safety and monitoring
needs.
Q3. Which of the following lists the five steps of the nursing process in the
correct order? [Multiple Choice]
A) assessment, planning, nursing diagnosis, implementation, evaluation
B) assessment, nursing diagnosis, planning, implementation, evaluation
C) assessment, nursing diagnosis, implementation, planning, evaluation
D) nursing diagnosis, assessment, planning, implementation, evaluation
Answer: assessment, nursing diagnosis, planning, implementation, evaluation
Explanation: The nursing process is a systematic sequence that starts with gathering information
(assessment), uses that information to identify problems (nursing diagnosis), sets goals and
chooses interventions (planning), carries out the interventions (implementation), and finally
judges whether the goals were met (evaluation). Each distractor is wrong because it disrupts that
logical order: swapping assessment and diagnosis skips the proper problem-identification step,
putting planning before diagnosis makes goals without a defined problem, and doing
implementation before planning skips development of an appropriate plan.
2
, Q4. Which phrase best describes a trade (brand) drug name? [Multiple Choice]
A) Nonproprietary, capitalized, suffixes, multiple names
B) Proprietary, not capitalized, marketing name, only 1 name
C) Proprietary, capitalized, marketing name, multiple names
D) Nonproprietary, not capitalized, suffixes, only 1 name
Answer: Proprietary, capitalized, marketing name, multiple names
Explanation: A trade (brand) name is owned by a company (proprietary), is written with
capitalization, used for marketing, and different companies may market the same drug under
multiple brand names. The first distractor is the definition of a generic name. The second
distractor is inconsistent because trade names are capitalized and may be multiple; saying 'not
capitalized' and 'only 1 name' makes it incorrect. The third distractor mixes generic and trade
features and is therefore incorrect.
Q5. Which set lists the four pharmacokinetic processes? [Multiple Choice]
A) Absorption, distribution, metabolism, implementation
B) Absorption, distribution, excretion, evaluation
C) Absorption, distribution, metabolism, excretion
D) Absorption, distribution, elimination, assessment
Answer: Absorption, distribution, metabolism, excretion
Explanation: Pharmacokinetics describes what the body does to a drug and includes absorption
(entry into the bloodstream), distribution (movement through the body), metabolism (chemical
alteration), and excretion (removal). The distractors are incorrect because they replace one of the
pharmacokinetic processes with terms from the nursing process (implementation, evaluation,
assessment) or with 'elimination,' which is a nonstandard swap for the source term 'excretion'
and therefore not the exact listed process.
Q6. Which best defines 'toxicity' as used in the drug context? [Multiple Choice]
A) the secondary effect of a drug that is unintended
B) immune response caused by hypersensitivity not dosage
C) undesirable drug effect
D) adverse drug reaction caused by excessive dosing
Answer: adverse drug reaction caused by excessive dosing
3
(Latest 2026/2027 Update) 100% Verified
Actual Questions & Answers | Grade A -
Herzing University
This NSG 124 Exam 1 practice resource is a comprehensive study guide designed to help
nursing students ace their foundational pharmacology exams. Featuring 100 carefully curated,
multiple-choice questions, it thoroughly breaks down essential drug classifications, therapeutic
effects, adverse reactions, and core nursing considerations.
Why This Practice Exam Sells
This resource is highly sought after by students because it focuses exactly on the most tested
concepts in first-year nursing pharmacology. Highlighting it with the following points will help
you attract buyers:
• Comprehensive ADME Coverage: Questions specifically test the core
pharmacokinetics principles: Absorption, Distribution, Metabolism, and Excretion.
• Detailed, Verified Answers: Every question includes a clear, evidence-based Answer
• Drug Classification Mastery: Helps students easily differentiate between chemical,
generic, and trade (brand) drug names, and understand concepts like the therapeutic
index and half-life.
• Real Nursing Scenarios: Features application-based questions that prepare students
for the critical thinking required in actual nursing school exams and clinical settings.
• Format: Delivered as a clear, instantly downloadable PDF that can be studied
anywhere, anytime.
Listing & Tags
• Title: NSG 124 Exam 1: 100 Practice Questions & Verified Answers
• Tags: NSG 124, Pharmacology, Nursing Exam 1, Herzing University, Practice
Questions, Test Bank, Study Guide
Q1. Explain what it means for a drug to be teratogenic and what outcomes it can
cause for a fetus. [Short Answer]
1
, Answer: A teratogenic drug can interfere with fetal development, resulting in congenital
malformations (birth defects) or causing fetal death. It implies the drug poses risks to the
developing embryo or fetus if exposure occurs during pregnancy.
Explanation: Teratogenicity refers to a drug's capacity to harm a developing fetus. A complete
answer notes that teratogens can produce structural defects (birth defects) or lead to loss of the
fetus (fetal death), and links this to the drug acting during developmental stages when the
embryo or fetus is vulnerable.
Q2. Which is preferable regarding a drug's therapeutic range? [Multiple Choice]
A) A low therapeutic index
B) No difference between narrow and wide
C) Narrow therapeutic range
D) Wide therapeutic range
Answer: Wide therapeutic range
Explanation: A wide therapeutic range is preferable because it provides a larger margin between
effective and toxic concentrations, making dosing safer and less likely to cause toxicity. A narrow
therapeutic range means there is a small margin for error and higher risk of toxicity. 'A low
therapeutic index' signals increased risk (the opposite of a wide safe margin). Saying 'no
difference' is incorrect because the width of the therapeutic range affects safety and monitoring
needs.
Q3. Which of the following lists the five steps of the nursing process in the
correct order? [Multiple Choice]
A) assessment, planning, nursing diagnosis, implementation, evaluation
B) assessment, nursing diagnosis, planning, implementation, evaluation
C) assessment, nursing diagnosis, implementation, planning, evaluation
D) nursing diagnosis, assessment, planning, implementation, evaluation
Answer: assessment, nursing diagnosis, planning, implementation, evaluation
Explanation: The nursing process is a systematic sequence that starts with gathering information
(assessment), uses that information to identify problems (nursing diagnosis), sets goals and
chooses interventions (planning), carries out the interventions (implementation), and finally
judges whether the goals were met (evaluation). Each distractor is wrong because it disrupts that
logical order: swapping assessment and diagnosis skips the proper problem-identification step,
putting planning before diagnosis makes goals without a defined problem, and doing
implementation before planning skips development of an appropriate plan.
2
, Q4. Which phrase best describes a trade (brand) drug name? [Multiple Choice]
A) Nonproprietary, capitalized, suffixes, multiple names
B) Proprietary, not capitalized, marketing name, only 1 name
C) Proprietary, capitalized, marketing name, multiple names
D) Nonproprietary, not capitalized, suffixes, only 1 name
Answer: Proprietary, capitalized, marketing name, multiple names
Explanation: A trade (brand) name is owned by a company (proprietary), is written with
capitalization, used for marketing, and different companies may market the same drug under
multiple brand names. The first distractor is the definition of a generic name. The second
distractor is inconsistent because trade names are capitalized and may be multiple; saying 'not
capitalized' and 'only 1 name' makes it incorrect. The third distractor mixes generic and trade
features and is therefore incorrect.
Q5. Which set lists the four pharmacokinetic processes? [Multiple Choice]
A) Absorption, distribution, metabolism, implementation
B) Absorption, distribution, excretion, evaluation
C) Absorption, distribution, metabolism, excretion
D) Absorption, distribution, elimination, assessment
Answer: Absorption, distribution, metabolism, excretion
Explanation: Pharmacokinetics describes what the body does to a drug and includes absorption
(entry into the bloodstream), distribution (movement through the body), metabolism (chemical
alteration), and excretion (removal). The distractors are incorrect because they replace one of the
pharmacokinetic processes with terms from the nursing process (implementation, evaluation,
assessment) or with 'elimination,' which is a nonstandard swap for the source term 'excretion'
and therefore not the exact listed process.
Q6. Which best defines 'toxicity' as used in the drug context? [Multiple Choice]
A) the secondary effect of a drug that is unintended
B) immune response caused by hypersensitivity not dosage
C) undesirable drug effect
D) adverse drug reaction caused by excessive dosing
Answer: adverse drug reaction caused by excessive dosing
3
